Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyRegional therapyVisceral SurgeryDiseaseEsophageal CancerGastric CancerPeritoneal Carcinomatosis, SecondarySubgroupAdenocarcinoma of the esophagogastric junction (AEG)ICD10C15.-C16.-C16.0C78.6MeSHEsophageal NeoplasmsStomach NeoplasmsSequenceAntineoplastic therapySubstanceCisplatinSubstanceCisplatinSubstanceCisplatinSubstanceCisplatinNo. Substances1 RadiotherapySupportive therapySubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSubstanceDexamethasoneFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateNo. Substances5Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationTherapy phaseintraoperativTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorGötze TDiseaseLokalisiertes oder lokal fortgeschrittenes Magen-Ca oder Karzinom des gastroösopagealen Übergangs Typ II/IIIOriginPREVENT - FLOT9 trial of the AIO / CAOGI / ACOProtocols in Revision 1 protocol foundHIPEC - Cisplatin 75, Adenocarcinoma Esophagogastric Junction and Stomach (PID2710 V1.1)
